Gender-Specific Combination HIV Prevention for Youth in High Burden Settings (MP3-Youth) (MP3-Youth)

MP3 Youth is a pilot study to evaluate the feasibility and acceptability of a gender-specific combination HIV prevention package for youth (aged 15-24) in high burden settings. The study aims to pilot a combination package of gender-specific interventions in western Kenya in a mobile health delivery format using integrated services delivery.

Study Overview

• Status: Completed
• Conditions: HIV; Adolescent Behavior; Gender
• Intervention / Treatment: Other: Male-Specific Intervention Package; Other: Female-Specific Intervention Package; Drug: Pre-Exposure Prophylaxis (Females); Behavioral: Cash Transfer Cohort (Females)

Detailed Description

The MP3-Youth study will provide critical information for design and evaluation of combination HIV prevention intervention packages that are sensitive to gender-specific risks among this most-at-risk population in high-HIV burden African settings. Our team of biobehavioral and clinical scientists, mathematical modelers, and trial design specialists will:

Aim 1: Identify gender (sex)-specific drivers of HIV acquisition risk, including pregnancy among females, for youth in sub-Saharan Africa, and interventions to best address those risks.

Aim 2: Conduct mathematical modeling to select optimal combination intervention package components and to assess potential population-level impact.

Aim 3: In partnership with a highly-productive nongovernmental organization (NGO) that is delivering PEPFAR-funded HIV prevention services, develop and pilot a combination HIV prevention package specific for female and for male youth - 'MP3-Youth' - in Nyanza Province, Kenya.

Aim 4: Design a phase IV study protocol for testing the effectiveness of a gender-specific youth HIV prevention package in sub-Saharan Africa. We will disseminate these research protocol recommendations, and study instruments including the mathematical modeling tool, as a combination prevention intervention research toolkit.

Design: Study activities comprise systematic review and meta-analysis of the HIV prevention literature for youth in sub-Saharan Africa; development of a mathematical modeling tool; and a community-based HIV combination prevention pilot that will take place in western Kenya. These activities will culminate in a testable combination HIV prevention trial protocol for youth, which is the main study deliverable.

Population: Aim 1: Focus groups will be held with male and female youth, parents, teachers, religious and community leaders. Aim 3: Pilot study will include male and female youths (ages 15-24) from Nyanza Province, Kenya.

Deliverables: Study deliverables include selection procedures for a population-specific combination HIV prevention package; measurement instruments, mobile prevention delivery protocols, mathematical modeling tools, and a testable study trial protocol. The entire MP3-Youth Package will be placed on a web site for open access.

• Study Type: Interventional
• Enrollment (Actual): 1215
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Kenya
  • Kisumu, Kenya
    • Impact Research and Development Organization
  • Nairobi, Kenya
    • University of Nairobi
• United States
  • New York
    • New York, New York, United States, 10003
      • New York University

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 15 years to 24 years (Child, Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Any male or female between the ages of 15-24.
• Able to understand spoken English or Kiswahili or Dholuo.
• Willing to give informed consent or if younger than 18 years of age has a parent or guardian willing to provide consent in addition to the minor's assent
• Willing to be tested for HIV.
• Willing to get participant ID based on biometric finger scan.

Exclusion Criteria:

• Any male or female younger than 15 or older than 24.
• Unable to understand spoken English, or Kiswahili or Dholuo.
• If under 18 and not an emancipated minor, unable to get parental consent.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Prevention
• Allocation: Non-Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

5

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Male-Specific Intervention Package; Gender-specific interventions targeted specifically for boys offered in an integrated services delivery modality. Cross-Sectional Arm.	Other: Male-Specific Intervention Package; Combination HIV Prevention: Male-Specific Intervention Package at the Mobile Health events and longitudinal follow up of cohorts.; Other Names: HIV Counseling and Testing (HTC); Facilitated linkage to care for HIV+: ART/PMTCT; Condoms; Voluntary Medical Male Circumcision (VMMC)
Experimental: Female-Specific Intervention Package; Gender-specific interventions targeted specifically for girls offered in an integrated services delivery modality. Cross-Sectional Arm.	Other: Female-Specific Intervention Package; Combination HIV Prevention: Female-Specific Intervention Package at the Mobile Health events and longitudinal follow up of cohorts.; Other Names: HIV Counseling and Testing (HTC); Facilitated linkage to care for HIV+: ART/PMTCT; Contraception/Family Planning (FP); Pre-exposure Prophylaxis (PrEP); Conditional Cash Transfer (CCT)
No Intervention: HIV Positive Cohort (Males and Females); Behavioral data on HIV positive youth. Longitudinal Arm.
Experimental: Pre-Exposure Prophylaxis (Females); PrEP adherence and feasibility. Longitudinal Arm.	Drug: Pre-Exposure Prophylaxis (Females); Females 18-24 who are out of school.; Other Names: Truvada; Emtricitabine; Tenofovir disoproxil fumarate
Experimental: Cash Transfer Cohort (Females); School attendance, behavioral data, and feasibility. Longitudinal Arm	Behavioral: Cash Transfer Cohort (Females); Cash transfer for females (and their parents) who are aged 15-24 and enrolled in school.; Other Names: Behavioral Economics; Conditional Cash Transfer

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Intervention Uptake (acceptability) and Coverage (feasibility)	Coverage: The proportion of youth in the community who attend each mobile event (estimated from youth population denominator); Enrollment: The number of participants who consent to being enrolled in the study during each mobile event.; Uptake: The number of participants who choose one or more components of their tailored combination package (and which components).; Intervention Acceptability: Satisfaction with mobile event services	6 months

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Adherence to medication (HIV+ and PrEP cohort participants only) over 12 months	Adherence to once daily Truvada (PrEP) among HIV-uninfected eligible females and patterns of adherence and sexual HIV acquisition risk exposure (PrEP cohort participants only). Measured by self-report, eCAPs, and clinical assessments; monthly for first 6 months and every 3 months for the following 6 months and DBS for analysis of TFV/FTC: TFV-DP/FTC-TP at months 2 and 9.; Adherence to ART for positives (HIV+ cohort participants only). Measured by self-report monthly SMS: 0, 3, 6,9,12 months). POC CD4 and baseline viral load by dried blood spot will be measured at mobile event baseline and repeated at 12 months.	12 months

Other Outcome Measures

Outcome Measure	Measure Description	Time Frame
Feasibility of administering cash transfer to keep girls in school	Conditional Cash Transfer to reduce HIV risk by staying in school.	12 months

Collaborators and Investigators

• Sponsor: New York University
• Collaborators: University of Nairobi; Impact Research & Development Organization
• Investigators: Principal Investigator: Irene Inwani, MD, MPH, Kenyatta National Hospital: University of Nairobi, Kenya; Principal Investigator: Ann Kurth, PhD, CNM, New York University; Study Director: Jasmine Buttolph, MPH, New York University

Publications and helpful links

General Publications

• Buttolph J, Inwani I, Agot K, Cleland CM, Cherutich P, Kiarie JN, Osoti A, Celum CL, Baeten JM, Nduati R, Kinuthia J, Hallett TB, Alsallaq R, Kurth AE. Gender-Specific Combination HIV Prevention for Youth in High-Burden Settings: The MP3 Youth Observational Pilot Study Protocol. JMIR Res Protoc. 2017 Mar 8;6(3):e22. doi: 10.2196/resprot.5833.

Study record dates

Study Major Dates

• Study Start (Actual): November 1, 2014
• Primary Completion (Actual): March 23, 2016
• Study Completion (Actual): March 23, 2016

Study Registration Dates

• First Submitted: February 8, 2012
• First Submitted That Met QC Criteria: April 2, 2012
• First Posted (Estimate): April 5, 2012

Study Record Updates

• Last Update Posted (Actual): February 18, 2022
• Last Update Submitted That Met QC Criteria: February 2, 2022
• Last Verified: September 1, 2018

More Information

Terms related to this study

• Keywords: Adolescent; HIV; Mobile Health; Intervention Studies; Prevention & Control; HIV Testing; Gender; Pre-Exposure Prophylaxis; Cash Transfer; Combination prevention; Medical Male Circumcision
• Additional Relevant MeSH Terms: Molecular Mechanisms of Pharmacological Action; Anti-Infective Agents; Antiviral Agents; Reverse Transcriptase Inhibitors; Nucleic Acid Synthesis Inhibitors; Enzyme Inhibitors; Anti-HIV Agents; Anti-Retroviral Agents; Tenofovir; Emtricitabine
• Other Study ID Numbers: 1R01AI094607-1; 1R01AI094607 (U.S. NIH Grant/Contract)

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: Yes